IMPACT OF OBESITY AND METABOLIC SYNDROME ON CLINICAL PROFILE AND SHORT‑TERM OUTCOMES IN HOSPITALIZED MEDICAL PATIENTS.

Main Article Content

Dr Sharad Mishra
Dr Pushpendra Mishra
Dr Ankur Chhari
Dr. Shweta Pandey

Keywords

Metabolic syndrome; obesity; hospitalized patients; clinical outcomes; length of stay; India

Abstract

Background: Obesity and metabolic syndrome (MetS) are increasingly prevalent in hospitalized medical patients and contribute to adverse clinical outcomes. Despite global evidence, data from Indian tertiary care settings assessing clinical profiles and short-term outcomes remain limited.


Material and Methods: A cross-sectional observational study was conducted in the Department of General Medicine at a tertiary care teaching hospital over 12 months. One hundred consecutive adult patients (aged ≥ 18 years) admitted to medical wards were enrolled by non-probability consecutive sampling. MetS was diagnosed using International Diabetes Federation (IDF) 2006 criteria. Anthropometric, clinical, biochemical data, and short-term outcomes — length of hospital stay (LOS), complications (acute kidney injury, infections, arrhythmias), ICU transfer, and mortality — were recorded. Analysis used Student's t-test and Chi-square/Fisher's exact test (p < 0.05 significant).


Results: MetS prevalence was 46% (n = 46). MetS patients were older (56.2 ± 11.4 vs. 49.1 ± 12.9 years, p = 0.004), had higher BMI (30.2 ± 4.1 vs. 23.9 ± 3.6 kg/m², p < 0.001), and waist circumference (97.3 ± 8.2 vs. 83.2 ± 8.8 cm, p < 0.001). Hypertension (82.6% vs. 33.3%), T2DM (73.9% vs. 18.5%), dyslipidemia (78.3% vs. 25.9%), and ischemic heart disease (34.8% vs. 11.1%) were significantly higher (all p < 0.01). LOS was longer in MetS (7.6 ± 2.1 vs. 5.1 ± 1.8 days, p < 0.001). ICU transfers (30.4% vs. 11.1%, p = 0.018), infections (21.7% vs. 7.4%, p = 0.042), AKI (26.1% vs. 7.4%, p = 0.013), and arrhythmias (17.4% vs. 3.7%, p = 0.028) were elevated. Complete recovery was lower (65.2% vs. 88.9%, p = 0.007); mortality trended higher (8.7% vs. 3.7%, p = 0.283).


Conclusion: MetS affects nearly half of hospitalized medical patients and associates with greater comorbidities, prolonged LOS, increased complications, and poorer recovery. Routine screening and multidisciplinary care are recommended.residencyadvisor+1

Abstract 0 | Pdf Downloads 0

References

1. World Health Organization. Obesity and overweight. Fact sheet. Geneva: WHO; 2020.
2. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.
3. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome — a new worldwide definition. Lancet. 2005;366(9491):1059–62.
4. Kant R, Singh MD, Verma A. Profile of metabolic syndrome in newly detected hypertensive patients. J Family Med Prim Care. 2019;8(1):174–9.
5. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127(1):1–4.
6. Fanta K, Haile K, Getachew M, Shibeshi W. Prevalence and impact of metabolic syndrome on short-term prognosis in hospitalized patients with acute coronary syndrome. Vasc Health Risk Manag. 2021;17:167–76.
7. Lee SH, Chung JW, Kim BK, Chang WI, Cho SW, Hong SJ, et al. Influence of obesity and metabolic syndrome on clinical outcomes in patients with ischemic heart disease. J Cardiol. 2018;72(2):100–6.
8. Alexopoulos AS, Qamar A, Hutchins K, Bhatt DL, Becerra AZ, Nguyen XM. Impact of obesity on hospital complications and mortality in hospitalized patients with hyperglycaemia and diabetes. BMJ Open Diabetes Res Care. 2016;4(1):e000200.
9. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC guideline on the management of blood cholesterol. J Am Coll Cardiol. 2019;73(24):e285–350.
10. Zhou Y, Wang C, Shi K, Yin X. Association between metabolic syndrome and an increased risk of hospitalization for heart failure. Front Cardiovasc Med. 2021;8:698117.